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ABSTRACT 
INTRODUCTION: This study aimed to assess reproductive knowledge and use of 
contraception in women of reproductive age with cardiac disease or chronic 
hypertension attending outpatient clinics. 
METHODS: This was a prospective descriptive study. Women aged between 18 and 45 
years attending cardiac or hypertension clinics at Groote Schuur Hospital, Khayelitsha 
and Mitchells Plain Day Hospitals were recruited. The study tool was an administered 
questionnaire which included social, demographic and medical information, knowledge 
about their condition and the contraceptive history.  
RESULTS: Two hundred women were interviewed, 100 with cardiac disease and 100 
with chronic hypertension.  
Among the 84 cardiac and 90 hypertensive women who had previously been pregnant, 
there were 193 and 262 pregnancies respectively. Of these participants, 72% cardiac 
and 70% hypertensive women reported at least one unplanned pregnancy. Unemployed 
hypertensive women were more likely to have unplanned pregnancies (81%), than 
their employed counterparts (65%) (p <0.03). In the cardiac group employment did not 
affect planning of pregnancies. 
Forty cardiac and 46 hypertensive women were married. Married women in both 
groups had more planned pregnancies (46% cardiac, 43% hypertensive) in contrast to 
those who were not in a relationship (20% cardiac 21% hypertensive)(p<0.03 cardiac, 
p<0.006 hypertensive).  
Sixty two percent cardiac and 82 % hypertensive participants were aware of at least 
one possible complication from their medical condition while 44% cardiac and 52% 
hypertensive women knew about some obstetric complication resulting from their 





Out of 200 women, only 2 were unaware of any contraceptive methods. One hundred 
and fifty eight participants were using modern contraceptive methods. None of the 
women accessed contraception at their routine medical clinics and less than half had 
received contraceptive advice there. 
CONCLUSION: This study showed that many pregnancies among participants with 
medical conditions were unplanned, and there was poor knowledge about the impact of 
their medical condition on pregnancy. There is an unmet need for reproductive health 
education in women with medical conditions, and ideally this should be part of the 





















CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
1. CARDIOVASCULAR AND HYPERTENSIVE DISEASE IN PREGNANCY 
 
Cardiovascular disease in pregnancy is the leading cause of maternal mortality in many 
developed countries. In the United Kingdom (UK), it was responsible for 60% of indirect 
causes of maternal deaths (2.2/100000 live births) between 2006 and 2008, and has 
been on the rise over the past 3 decades.1,2 In South Africa, it is estimated that 
approximately 0.6% of pregnancies are affected by cardiac disease.1 Cardiac disease 
was responsible for 40% and 36.5% of maternal deaths from pre-existing medical and 
surgical conditions in the reports of the NCCEMD for the 2005-2007 and 2008-2010 
triennia respectively in South Africa.3,4 
 
Despite a dramatic decline in rheumatic heart disease in developed countries, it is the 
second most common cause of heart failure among Africans.5 In Africa, 500 000 new 
cases are diagnosed, and 350 000 patients die from rheumatic heart disease annually.5 
 
In South Africa, rheumatic heart disease is the most common cardiac pathology in 
pregnancy, occurring in 71 to 84% of pregnant cardiac patients.1 In Dakar, Senegal 34% 
of pregnant women with cardiac disease died between 1994 and 2004. Ninety two 
percent of these women had rheumatic heart disease.6 These statistics serve to 
emphasize the importance of diagnosis, good clinical management and pre-pregnancy 
counselling in women with cardiac disease. 
 
The commonest cardiac disease in pregnant women in developed countries is 
congenital cardiac disease which accounts for 80% of cases of cardiac pathology. More 
women born with congenital heart defects are now reaching child-bearing age and, with 





Despite ischaemic heart disease being responsible for only 20% of cardiac disease in 
pregnancy, it was responsible for most maternal deaths in pregnant cardiac patients in 
the UK.1 
Chronic hypertension is a common medical disorder encountered during pregnancy, 
which affects 10% of all pregnancies in the United States of America (USA).8 It is 
associated with adverse maternal and perinatal outcomes. The risks in pregnancy 
include exacerbation of hypertension, pre-eclampsia and its complications, intrauterine 
growth restriction, abruptio placentae and and premature delivery.8 
 
In South Africa, hypertensive disease in pregnancy was the second commonest cause of 
direct maternal death in the 2008-2010 triennium, and was responsible for 14% of all 
maternal deaths.4 Five percent of women who died from hypertensive disorders had 
chronic hypertension.   
 
In developing countries, the challenges of hypertension and cardiac disease include the 
impact on maternal and perinatal morbidity and mortality. Due to the resource 
constrained facilities which care for such high risk patients in pregnancy, optimal 
management is challenging. In many rural parts of South Africa, it may be difficult to 
manage high risk pregnant patients. This is largely due to lack of essential medical 
expertise and appropriate facilities. It is obvious that appropriate channels of referral 
must be in place. 
 
In 2004, cardiovascular disease was the commonest cause of death among all women, 
and was responsible for 31% of these deaths world-wide.9 More than 80% of deaths 
from cardiovascular disease in 2008 occured in low and middle income countries.10 
Changes in environmental and behavioural determinants of cardiovascular diseases e.g. 
increased tobacco and alcohol use, consumption of fattening and refined food, obesity, 
diabetes, and lack of exercise among women are responsible for the increase in 
cardiovascular morbidity and mortality.10 It is expected that the cardiovascular burden 
of disease will double from 1990 to 2020.10 Many deaths from cardiovascular disease 







In a survey in Limpopo Province in 2004, it was shown that the incidence of 
hypertension was 18% among women under the age of 45, with 28% of these women 
using tobacco and 31% being at least overweight.12 It was further calculated that 27% 
of the women in this survey had a 20% chance of developing cardiovascular events in 
the next ten years. Many of the patients with cardiovascular disease and hypertensive 
disorders are still in the reproductive age group, and will require special care to manage 
these conditions when pregnant. 
 
There is a general impression that pregnancy at advanced maternal age is on the rise, 
and is partly responsible for the increased incidence of cardiac disease and chronic 
hypertension in pregnancy.13 According to the South African Demographic and Health 
Survey (SADHS) in 2003, the prevalence of pregnancy among women over 35 years was 
16% in the period of five years prior to the survey.14 This was comparable to the 
findings by the National Health and Nutrition Examination Survey (NHANES) III, 1988–
1994 in the USA, with a prevalence of 16.1%.15 We obviously need new updated data to 
assess this adequately. 
 
2. PHYSIOLOGICAL CHANGES IN PREGNANCY 
 
The physiological adaptive changes that occur in the cardiovascular system in 
pregnancy are complex. These changes ensure that there is enough blood supply and 
nutrition to nourish the fetus, and result in a well grown and developed fetus at the end 
of the pregnancy.  The physiological adaptations may lead to cardiac deterioration in 
patients with underlying cardiac disease. After the pregnancy, it takes two to twelve 
weeks to return to the pre-pregnancy cardiac state.14 
 
 
An increase in total blood volume occurs as early as the first trimester, reaching its peak 





mass respectively.  A further increase in total blood volume results from auto-
transfusion of blood from the uterus following delivery.16 Cardiac output increases by 
40% (from 4.5 to 6 l/min at rest), and this change is as a result of increased stroke 
volume and a modest increase in heart rate. Stroke volume is dependant on increased 
preload (increase in blood volume), contractility ability and muscle mass of the heart.16  
 
Systemic blood pressure (both systolic and diastolic) drops from the first trimester, 
reaching the lowest levels during pregnancy in the second trimester, and rises to non-
pregnant levels again in the third trimester. This phenomenon is a result of a 30% fall in 
peripheral vascular resistance due to systemic vasodilatation mediated by 
progesterone, oestrogen, prostaglandins and nitric oxide, and the growing utero-
placental unit.17 
 
From the first stage of labour, with each uterine contraction, auto-transfusion occurs 
whereby blood from the uterus is expelled into the systemic circulation. This results in 
increased preload, increase in cardiac output by 2.5 l/min, and increased blood 
pressure.17 A further 80% increase in cardiac output occurs after delivery due to 
autotransfusion from uteroplacental unit and relief of inferior vena caval obstruction.18 
 
Pregnancy and, especially the puerperium, are associated with a high procoagulant state 
due to increased production of clotting factors; particularly fibrinogen, decreased 
Protein S, and suppressed fibrinolytic pathway.19 Increase in fibrinogen levels begin 
from the 10th week, with a steady rise throughout the pregnancy and puerperium. This 









3. CARDIAC DISEASE 
3.1 PREGNANCY AFFECTS CARDIAC DISEASE 
The adaptive cardiovascular changes in pregnancy puts a great strain on patients with 
pre-existing cardiac disease, sometimes to the detriment of the mother and the fetus. 
The commonest causes of death in pregnant women with cardiac disease are pulmonary 
oedema, thromboembolic disease, and haemorrhage from anticoagulants.1 In pre-
existing cardiac disease, additional blood volume can lead to pulmonary oedema.  
 
The physiological increase in resting heart rate, cardiac output, ectopic beats and total 
blood volume together with the decrease in systemic vascular resistance contribute to 
development of new cardiac arrhythmias. These are more common in enlarged hearts.22 
 
Iron deficiency anaemia is the most common haematological condition in pregnancy, 
and can result in increased heart rate and cardiac output, leading to high output cardiac 
failure. Pregnant patients are more prone to infections, particularly of the urinary and 
respiratory tracts, and in cardiac patients these can also result in a high output state, 
further aggravating heart failure. 
 
The procoagulant state of pregnancy can cause thrombosis of abnormal and prosthetic 
valves, mural thrombi in poorly contractile heart chambers, and venous circulation. 
Pulmonary thromboembolic disease will worsen pulmonary hypertension, and 
thrombosis of valves leads to heart failure. Embolism from cardiac wall mural thrombi 







Bioprosthetic valves are less thrombogenic, and do not require anticoagulation. They 
are, however, less durable than metallic valves and tend to deteriorate quicker in 
younger patients. The rate of failure in bio-prosthetic valves after 10 years of placement 
among patients younger than 40 years is 20% to 30%.20 Repeat surgery exposes 
patients to a 5% mortality rate.19 
 
Cardiac patients in labour are especially vulnerable to pulmonary edema due to 
increased cardiac output and blood pressure as a result of uterine contractions, pain, 
and fluid overload.18 Epidural anaesthesia in cardiac patients helps to reduce pain and 
hence the risk of pulmonary oedema from pain-induced tachycardia.22 In patients with 
fixed cardiac output, however, the epidural anaesthesia causes peripheral vasodilation 
secondary to sympathetic blockade and results in reduction in venous return.23 Cardiac 
output will fall which may precipitate heart failure.  
 
Cardiac patients need careful monitoring by experienced anaesthetists and use of 
inotropic drugs may be necessary.24 Caesarian section carries an additional risk due to 
blood loss, anaesthesia, and risk of sepsis. Risk of haemorrhage is further increased if 
the patient is anticoagulated.19 
 
3.2 CARDIAC DISEASE AFFECTS PREGNANCY 
Cardiac disease in pregnancy is associated with higher fetal loss when compared to 
pregnancy without heart disease, with perinatal mortality ranging from 9 to 24 per 1 
000 deliveries.1 A small study in Pakistan looked at perinatal outcome of patients with 
cardiac disease, and reported 18% of babies were small for gestational age, 3% were 
still born, and 3% had an early neonatal death due to prematurity.25 
 
In the USA, a cohort study of women with congenital heart disease in pregnancy found 
that 25% of pregnancies had adverse neonatal outcomes.26 Premature delivery 
occurred in 20%, small for gestational age infants in 8.3% and respiratory distress 





Association (NYHA) class III-IV, maternal cyanosis, maternal left heart obstruction, 
smoking during pregnancy, multiple pregnancy, and use of anticoagulants throughout 
pregnancy.26 
 
In mothers with congenital heart disease, the risk of congenital heart defect in the fetus 
is higher than in general population. The risk of an affected fetus varies with the nature 
of the heart lesion, for Tetralogy of Fallot it is 2.5% and with congenital aortic stenosis, 
18%. If a congenital heart defect is present in the fetus, there is a 5% risk of an 
associated chromosomal anomaly in the affected fetus. It is recommended that fetal 
echocardiography is performed at 18 to 22 weeks in women with congenital heart 




4.1 PREGNANCY AFFECTS HYPERTENSIVE DISEASE 
In hypertensive patients with renal disease, whether as a secondary cause or a 
complication of hypertensive disease, pregnancy can lead to clinical deterioration of 
renal function. Women with moderate to severe renal impairment, systemic lupus 
erythematosus (SLE), mesangiocapillary glomerulonephritis, renal scleroderma and 
polyarteritis nodosa tend to decompensate when they become pregnant.The latter two 
conditions are considered to be absolute contraindications to pregnancy.28 
 
4.2 HYPERTENSION AFFECTS PREGNANCY 
The risk of pre-eclampsia, and its complications in patients with chronic hypertension, 
is 17-25%.29 A prospective interventional study done in the UK and Netherlands 
showed that 22% of pregnant women with chronic hypertension developed 
superimposed pre-eclampsia. Forty four per cent of patients with superimposed pre-






Chronic hypertension without pre-eclampsia, is an independant risk factor in 
pregnancy. In a study in the USA the incidence of preterm births in patients with chronic 
hypertension was almost 15%, compared to background risk of 9.6%.31 Chronic 
hypertension in the study by Chapell et al also carried a risk of abruptio placentae 
(1.56%), fetal growth restriction (up to 50%), stillbirth (2%) and neonatal death 
(1%).30 
 
The risks are significantly higher in the presence of severe hypertension, target organ 
damage predating the pregnancy, and in secondary causes such as vasculopathies, renal 
disease, and endocrinopathies.28 
 
5. MEDICATION AND PREGNANCY 
Some medication used to treat cardiac disease and hypertension is known to be 
teratogenic, and should be adjusted when pregnancy is planned or confirmed.  
 
The incidence of warfarin embryopathy when warfarin is administered in the first 
trimester is 0.6-10%, and is dose-dependent, reaching 8% when given in doses of more 
than 5mg a day between 6 and 12 weeks.19 The risk of fetal intraventricular 
haemorrhage is always present when warfarin is used throughout the pregnancy, and is 
especially increased when the INR is above therapeutic levels.  
 
The long half-life of warfarin may cause haemorrhagic disease of the newborn if 
warfarin has not been stopped timeously before delivery. Vaginal delivery in patients 
who are fully anticoagulated with warfarin is contra-indicated because it may result in 
intracranial haemorrhage in the fetus.19 Caesarian section has then to be performed 
under general anaesthesia, with the possible complications from the anaesthesia and 






Angiotensin Converting Enzyme (ACE) - inhibitors are known to cause fetal renal 
dysgenesis with resultant oligohydramnios in 14% and anuria in 15% of exposed 
cases.31 They are also associated with renal failure, pulmonary hypoplasia, intrauterine 
growth restriction and fetal death, and should be avoided in all the trimesters. Certain 
beta-blockers, particularly atenolol, are associated with fetal growth restriction.32 
 
Alternative and less teratogenic treatment options may be less effective, and 
compromise the health of the patient. Heparin is the anticoagulant preferred to warfarin 
because it does not cross the placenta. In patients with prosthetic valves, it is usually 
used instead of warfarin from 6-12 weeks to avoid teratogenicity33, and from 36 weeks 
to avoid prolonged anticoagulation in the fetus, and the mother. It is less effective than 
warfarin as an anticoagulant. In a review by Chan et al (2000), the risk of valve 
thrombosis when unfractionated heparin was used was 9.2% compared to  3.9% when 
using warfarin in pregnancy.33 The case fatality rate from valve thrombosis has been 
reported to be 15%.17 
 
Unfractionated heparin requires parenteral administration, more frequent monitoring, 
and it carries a risk of drip site sepsis and infective endocarditis. Long-term use of 
heparin of more than eight months is associated with osteoporosis. Unfractionated 
heparin given throughout the antenatal period is associated with a 5% decline in bone 
mineral density (BMD).34 Heparin-induced thrombocytopenia (HIT) is caused by 
antibody-mediated destruction of platelet-heparin complexes. It is a life-threatening 
complication associated with unfractionated heparin use, and not low molecular weight 
heparin. The risk is low in pregnancy (0.1 %).35  
 
Methyldopa has been discontinued for decades as a mainstream antihypertensive agent 
in the general population. In pregnancy, it has the longest fetal safety track record, and 
is often used as a first line antihypertensive in pregnancy. Due to its long onset of action, 





causes somnolence, dizziness, and depression, and may be less well tolerated than 
modern antihypertensives.32 
 
6. STRATEGIES TO REDUCE MATERNAL MORTALITY 
South Africa was among 189 countries that committed to  the 8 Millennium 
Developmental Goals (MDG) at the Millennium Summit in September 2000.36 
Millennium Development Goal (MDG) 5(a) intended to reduce maternal mortality ratio 
by 75% from 1990 to 2015, and MDG 5(b), (added in 2007) to achieve universal access 
to reproductive health. The South African National Committee for Confidential Enquiry 
for Maternal Deaths (NCCEMD) provides key recommendations to prevent maternal 
deaths.3  
• Improving health care provider knowledge and skills in providing emergency 
care and ensuring adequate screening and treatment of the major causes of 
maternal death. 
•  Improving quality and coverage of reproductive health services, namely 
contraception and termination of pregnancy services. 
• Management provision of staffing and equipment norms, transport and 
availability of blood for transfusion. 
• Community involvement and empowerment regarding maternal, neonatal and 
reproductive health in general 
 
Despite these strategies, the maternal mortality rate remains very high in South Africa 
and we will fail to meet MDG 5(a) by 2015. In Sub-Saharan Africa, maternal mortality 
rate per annum has been dropping at a steady rate of only 1% per annum instead of 
recommended 5.5% to meet MDG 5 by 2015, and it is unlikely that the other Sub-






Sri Lanka, a low-income country, has, however, managed to reduce their maternal 
mortality rate from 2140/100 000 in the 1930’s to 38/100 000 live births in 2004 by 
their Safe Motherhood programme. The programme ensures that contraception and 
maternity care are accessible to all women from different communities.38 This indicates 
the possibility of reducing maternal morbidity with well-structured and supported 
contraceptive programmes. 
 
6.1 CONTRACEPTION  
The most obvious primary prevention of maternal mortality is to prevent unintended 
pregnancies with appropriate use of modern contraception. It is imperative that women 
with medical conditions use effective contraceptive methods to reduce the additional 
burden of disease associated with pregnancy, until their condition has been optimised. 
 
Family planning is one of the great public health achievements of the 20th century 
especially in developed countries, where it is widely accepted and used. In 2002 61% of 
all women and 72% of married women in the USA used contraception.38 In South Africa, 
some modern contraceptive methods are offered free of charge in public health facilities 
and are essential components of primary health care services.  The SADHS in 2003 
showed that 83% of women using contraception obtained their methods from the 
public health sector and mostly at primary health care centres.14 
 
Uptake of contraception by women in developing countries has steadily increased 
between 1990 and 2005.38 In Ethiopia, use of modern contraceptive methods increased 
from 6% in 2000 to 30% in 2009 among married women aged 15–49 through education 
and extended family planning services.6 
 
WHO has noted a slow expansion of the use of contraception in some developing 
countries, particularly Sub-Saharan countries and, as a consequence, the number of 





is lowest among the poorest, uneducated women especially in rural areas. In Sub-
Saharan African surveys, only 22% of women, married or in union, between 15 to 49 
years of age used contraception in 2007.38  
 
Inconsistent use of contraception and unintended pregnancy rate remain very high in 
South Africa. A community survey conducted in Potchefstroom reported that 60% of 
pregnancies were unintended despite seemingly high contraception use (69%) and 
knowledge (93%).39 
 
 In North America it has been demonstrated that the commonest reasons for engaging in 
unprotected coitus were barriers to access to contraception (49%), unplanned coitus 
(45%), and not believing in the possibility of falling pregnant (42%).40 Wood and Jewkes 
(2006) found that the low use of contraception among women in Limpopo was due to 
poor knowledge regarding contraception, fear of adverse effects, unaddressed 
misconceptions, and social and logistical barriers to access the service.41  
 
Contraception use was associated with stigma among University of Natal students (male 
and female) participating in a survey to assess contraception and abortion knowledge.42 
More than 40% of participants believed that women who use contraception were 
promiscuous. Only 60% believed that contraception prevented pregnancy, and 12 % 
believed that it did not. University students are more educated than the average South 
African population, and more knowledge about contraception and less prejudice would 
be expected in this group. 
 
Unintended pregnancies add to the risk of termination of pregnancy (TOP) and 
associated complications. Despite the Choice of Termination of Pregnancy Act of 1996 
and TOPs being offered free of charge in public health facilities, many women in South 





abortions is not known, but it is estimated that that 450 women die annually from 
illegal TOPs in South Africa.44 
 
6.2 PRECONCEPTION CARE 
The United Kingdom Centre for Maternal and Child Health Enquiries (CMACHE) 
recommends that  women of child-bearing age with pre-existing medical and 
psychiatric conditions should be offered preconception counselling.2 This should be 
routinely offered at every level of care and the opportunity for proactive counselling is 
always available whenever patients interact with health care facilities.  
 
Discussion should begin from the time when acquired heart disease or chronic 
hypertension are diagnosed and at menarche when congenital heart disease is present. 
It should continue at regular intervals even when the patients do not raise their own 
reproductive issues. Topics should include contraceptive options, and plans about 
childbearing, if relevant. 
 
Counselling should cover risks that pregnancy would add to the medical conditions, and 
the risk that the medical conditions would pose to the health of both patient and fetus 
during pregnancy. Patients should be made aware of any teratogenic medication they 
use, and should be counselled about the need to adjust therapy when conception is 
planned. 
 
When considering pregnancy, women should be assessed while on contraception. If 
they are medically unwell before pregnancy, they are likely to decompensate during 






Women who do not desire to fall pregnant can be counselled on various contraceptive 
methods available, and offered the most suitable method for cardiac disease or 
hypertension. Women utilizing contraception should be assessed for satisfaction and 
side-effects of the methods they currently use, and alternative contraception be offered 
if necessary. Side-effects from contraception are common reasons for discontinuation in 
women not planning to conceive41 and may result in unintended pregnancies which 
compromise the woman’s health.  
 
6.3 ANTENATAL CARE 
Eighteen per cent of South African women who died from cardiac disease in the last 
triennium (2008-2010) did not receive antenatal care.4 In South Africa the Minister of 
Health announced the introduction of free health care services for pregnant women and 
children under the age of 6 years in July 1994. The SADHS in 2003 reported that 92% of 
pregnant women attended at least one antenatal clinic (ANC) visit and about three-
quarters had at least four visits before delivery.14   
 
Moodley et al reported that despite 94% of pregnancies being confirmed by 4 months of 
amenorrhoea, only 23.4 % booked before 20 weeks.45 The rest of the women either did 
not book (28.7 %), or booked later than 20 weeks (47.9%). Myer and Harrison (2006) 
reported that women who booked late lacked education about the importance of 
antenatal care. More than 50% believed that they could not book before fetal 
movements were felt, despite confirmed pregnancy status. Some did not see any benefit 
to antenatal care, and perceived early booking as an unnecessary inconvenience.46 
 
In a community based cross-sectional study in Empangeni KZN, the authors reviewed 
the knowledge of danger signs, or pregnancy complications, and HIV status among 
pregnant women.47 Knowledge of danger signs, which were used as a surrogate marker 
for antenatal health education, was found to be lacking in almost half of women who 





7. AIMS AND OBJECTIVES 
Because of the high maternal mortality in women with cardiac disease and 
hypertension, we wished to assess the knowledge of their medical disorders in women 
with cardiac or hypertensive disease in relation to their reproductive practices. 
 The aims and objectives of the study were to assess among affected women:  
 Past and current use of contraception among women with cardiac disease and 
chronic hypertension  
 Knowledge of the impact of cardiac disease and chronic hypertension on 
pregnancy 
 Knowledge of impact of pregnancy on cardiac disease and chronic hypertension  
 Knowledge of contraception among women with cardiac disease and chronic 
hypertension 
 Accessibility of contraception and contraceptive advice to women with cardiac 














CHAPTER 2: METHODS 
 
This was a prospective descriptive study.  The protocol was approved by the Human 
Research Ethics Committee of University of Cape Town in January 2013 (HREC Ref: 
565/2012) (see appendix 1). 
PARTICIPANTS 
The study population was recruited by convenience sampling at the various clinical 
sites, and consisted of women of reproductive age with chronic hypertension or cardiac 
disease. The convenience sampling method was chosen because it was the most 
practical.  The proportion of eligible participants was very small, and the majority of 
patients attending the clinics were not suitable for the study. All the patients that 
fulfilled the criteria for the study were approached.  
Inclusion criteria:  
 Women between ages of 18 and 45 years 
 Women with cardiac disease or chronic hypertension attending cardiac or 
hypertension  clinics  
 Patients willing to consent to participation in the study 
 Exclusion criteria: 
 Women who were pregnant at the time of the study. These women were 
deliberately excluded as we believed that discussing pregnancy complications 
could arouse  excessive anxiety and distress during their index pregnancies. 
 Women who were unwilling to participate 
 Women who could not understand the study 







Questionnaires for patients with hypertensive disorders and cardiac disease were 
designed (see appendix 2 and 3). The structure of the questionnaire was adapted for the 
hypertensive and cardiac group from a previously approved questionnaire from 
contraception studies that have been previously conducted in the Reproductive 
Medicine Unit within the Department of Obstetrics and Gynaecology. Each 
questionnaire had some specific questions relevant to cardiac disease and hypertensive 
disorders. The questionnaires contained 83 open and closed-ended questions, and 
questions were asked in the same order in both questinnaires. They covered the 
following areas: 
 Demographics: Age, population group, religion, home language, marital 
status, educational background, economic status, 
 Social history, including marital status, and substance use 
 Detailed medical history and medication 
 Detailed obstetric history 
 Knowledge of impact of pregnancy on the medical condition. 
 Knowledge of impact of medical condition on pregnancy 
 Knowledge of contraception. History of contraceptive use 
 Accessibility of family planning services to patients 
English and Xhosa versions of the questionnaire were available.  The questionnaire was 
initially piloted in 10 hypertensive and 10 cardiac patients, and modified as necessary. 
The questionnaires were administered by the principal investigator and, well-trained 
experienced full-time research nurses from the Reproductive Medicine Unit at 
University of Cape Town. 
 
The study proposal was presented to the Head of the Hypertension Unit, Prof Bryan 





both gave permission for the investigators to recruit at Groote Schuur Hospital. We 
were given permission from the Provincial Department of Health to recruit at the 
special clinics in Khayelitsha and Mitchells Plain Community Health Centres. 
 
RECRUITMENT 
 All the investigators who participated in the study were trained by senior research 
nurses within the Reproductive Medicine Unit who are employed by the University of 
Cape Town. Recruitment occurred from 2 February 2013 until  31 August 2013, initially 
at the Cardiac and Hypertension clinics, Groote Schuur Hospital and later at 
Hypertension and INR clinics in Mitchells Plain and Khayelitsha Community Health 
Centres. The nursing sisters and clerks at the clinics were informed about the study but 
were not involved in recruitment. They allowed the investigators to identify folders of 
women who would be suitable by date of birth from the folder cover.  
 
We then approached all women who fulfilled the criteria in the waiting rooms, and 
asked for their permission to participate in the study. We explained the objective of the 
study and how we were going to collect data, and supplied them with information 
leaflets (see Appendix 4). Women who were willing to participate were asked to 
provide written consent (Appendix 5).  The original questionnaires and consent forms 
were kept in Reproductive Medicine Unit office in a secure environment.  
 
DATA CAPTURING AND ANALYSIS 
Information from completed cardiac and hypertension questionnaires was coded and 
entered into a database using Windows Excel spread sheets. Data were re-entered and 
double checked for any errors.   Data were analysed by Miss Ushma Galal from the 







Continuous data was displayed using boxplots. It was analysed using Wilcoxon-Mann-
Whitney U-test because the data was abnormally distributed. Categorical data were 
presented as two-way contingency tables. As most of the tables had cells with expected 
counts of less than 5, Fisher’s exact test was used instead of Chi Square test to assess 
associations between groups. Because the Fischer’s exact test yields similar results as 
the Chi Square test when expected count is above 5, for consistency, the statistician 
chose to use the Fischer’s exact test for all categorical data. A p-value <0.05 was 




















CHAPTER 3: RESULTS 
We recruited patients attending cardiac and hypertension specialist clinics at Groote 
Schuur Hospital, Khayelitsha and Mitchells Plain Community Health Centres. We 
identified 104 hypertensive and 102 cardiac women who were eligible for the study. 
Only 4 hypertensive and 2 cardiac patients declined to participate due to time 
constraints. One hundred women from each group were interviewed. 
DEMOGRAPHIC HISTORY 
Figure one shows age distribution with mean age and IQR of participants in both 
groups. The mean age of the cardiac participants was 35.25 years (range 19.75-45.92) 
while the hypertensive women were slightly older (mean 38.66 years, range 18.07-
45.92) (Wilcoxon-Mann-Whitney U-test p = 0.033). 












The ethnicity of the participants is presented in Table 1. The interviews were conducted 
in English and Xhosa. 
TABLE 1: ETHNICITY OF PARTICIPANTS 
 BLACK SA COLOURED WHITE FOREIGN TOTAL 
CARDIAC 43 49 3 5 100 
HYPERTENSION 54 41 3 2 100 





Religious affiliations were similarly distributed in both groups. There were 80 cardiac 
and 82 hypertensive women who belonged to Christian religion. The rest belonged to 
Islamic religion (16 cardiac and 18 hypertensive women). Four cardiac women were 
affiliated to a traditional African religion.  
 
The number of married women in both groups was comparable (40 cardiac and 46 
hypertensive patients). Among the participants, there were 22 cardiac and 10 
hypertensive women who were single and not in a relationship (Table 2).  
TABLE 2: MARITAL STATUS OF PARTICIPANTS 
 CARDIAC HYPERTENSION 
SINGLE NOT IN A RELATIONSHIP 22 10 
STABLE RELATIONSHIP, NOT COHABITING 24 26 
STABLE RELATIONSHIP AND COHABITING 5 6 
MARRIED 40 46 
DIVORCED 6 4 
SEPARATED 3 5 
WIDOWED 0 3 
TOTAL 100 100 
 
The majority of participants had some level of secondary education (n=167). Eighteen 
had only primary education and 15 had completed tertiary education (Table 3).  
There was no statistical significant difference in education between the two groups 
(Fisher’s Exact test p=0.343)  
TABLE 3: EDUCATION LEVEL OF PARTICIPANTS 
 
CARDIAC HYPERTENSION 
PRIMARY SCHOOL  6  12  
HIGH SCHOOL NO MATRIC 51  53  
MATRIC, NO TERTIARY 36  27  
TERTIARY COMPLETE 7  8  






The smoking and alcohol history is shown in Table 4. A total of 8 hypertensive women 
had used cannabis and at the time of the study there was only one current user. None of 
the cardiac women had used recreational drugs.  
TABLE 4: SOCIAL HABITS OF PATICIPANTS 
 CARDIAC HYPERTENSION 
CIGARETTE SMOKING n n 
     YES 19 17 
     NO 67 71 
     STOPPED <6 months ago 0 1 
     STOPPED >6 months ago 14 11 
ALCOHOL CONSUMPTION n n 
      YES  22 18 
      NO  61 65 
      STOPPED <6 months ago 1 2 
      STOPPED > 6 months ago 16 15 
DRUG USE n n 
     YES 0  1  
     NO 100  92  
     STOPPED <6 months ago 0  1  
     STOPPED >6 months ago 0  6  
TOTAL 100  100  
 
EMOTIONAL AND SOCIO-ECONOMIC HISTORY 
Most of the women in both groups felt that they had emotional support. Twenty eight 
cardiac and 23 hypertensive women had at least two sources of support. There were, 
however, 5 cardiac women all of whom were unmarried and 3 hypertensive women 2 of 












TABLE 5: EMOTIONAL SUPPORT OF PARTICIPANTS 
NUMBER OF 
SOURCES CARDIAC HYPERTENSION 
0 5  3  
1 65 74  
2 18  23  
3 10  0  
5 1  0  
6 1  0  
Total 100  100  
 
Employment is shown in Table 6. Thirty six cardiac and 35 hypertensive women were 
unemployed, 18 cardiac and 7 hypertensive women received disability grants, and 34 
cardiac and 41 hypertensive women had formal low to middle income jobs. Eighteen 
cardiac and seven hypertensive women received disability grants. All participants had 
financial support, often from more than one source (Figure 2). 
TABLE 6: EMPLOYMENT OF PARTICIPANTS 
  CARDIAC HYPERTENSION 
Unemployed 36  35  
Self-employed 5  9  
Casual employment 6  18  
Formal employment 28  23  
Student/scholar  2  2  
Housewife 5  5  
Disability grant 18  7  
Charity work 0  1  












FIGURE 2: FINANCIAL SUPPORT OF PARTICIPANTS 
 
None of the women were homeless, although some of the housing appeared to be 
suboptimal (Table 7). The difference in housing between the two groups was 
statistically significant (Fisher’s exact test p=0.05), with more of the hypertensive 
patients utilizing informal housing. 
TABLE 7: HOUSING OF PARTICIPANTS 
 
CARDIAC HYPERTENSION 
Formal housing on separate 
stand 33  32  
Flat 12  7  
Semi-detached house 16  8  
Separate entrance 7  6  
Wendy house 9  4  
Shack 20  42  
Room in main dwelling 3  1  
TOTAL 100  100  
 
SEXUAL AND CONTRACEPTION HISTORY 
Two cardiac and 3 hypertensive women who were interviewed had never been sexually 
active. The mean age of first coitus in cardiac and hypertensive women was 19.1 (IQR 







TABLE 8:  AGE AT FIRST COITUS OF PARTICIAPNTS 
  Min.    1st Qu. Median  Mean    3rd Qu. Max.    
CARDIAC 14.00 17.00 18.00 19.18 21.00 29.00 
HYPERTENSION 11 16.00 18.00 18.15 20.00 27.00 
 
The mean age of first contraception use was 20.6 years (12-34) in cardiac and 19.4 
years (10-35) in the hypertension group. Most women (56 cardiac and 58 hypertensive) 
had a lag period of at least one year between first intercourse and initiating 
contraception use. Twenty six cardiac and 24 hypertensive women initiated coitus and 
contraception simultaneously, while 11 cardiac and 12 hypertensive women initiated 
contraception after intercourse. There were 5 cardiac and 3 hypertension women 
whose data were categorised as missing who either could not remember first coitus or 
first contraception (Table 9). 
TABLE 9: FIRST COITUS IN RELATION WITH FIRST CONTRACEPTION 
  CARDIAC HYPERTENSIVE 
COITUS BEFORE CONTRACEPTION 56 58 
COITUS WITH CONTRACEPTION 26 24 
COITUS AFTER CONTRACEPTION 11 12 
NEVER HAD COITUS 2 3 
MISSING DATA 5 3 
TOTAL 100 100 
 
At the time of the interview, 75 cardiac and 73 hypertensive women were using 
contraception. There were 19 cardiac and 22 hypertensive women who had 
discontinued contraception. Five of the 6 cardiac and 3 of the 5 hypertensive women 
who had never used any contraceptive method were sexually active. Current 
contraceptive use was not affected by emotional support (Fisher’s exact test p=1.000 in 
both groups).  
 
The most commonly used methods of contraception among cardiac women were female 





women who were more than 10 years from their diagnosis were more likely to be 
sterilised than those with a duration of disease less than 10 years, however this did not 
reach statistical significance (Wilcoxon p-value=0.237). Among hypertensive women, 
injectable progestogens (n=33), female sterilisation (n=20), and male condom (n=11) 
were the most common contraceptive choices. Only two women from both groups used 
male condoms with another contraceptive method. There was one patient from each 
group who was using the IUCD at the time of the interview. There were only 2 
hypertensive women who used the intrauterine system (IUS). Long-term implants and 
female condoms were not used by any patients interviewed (Figure 3).  
 
FIGURE 3: CURRENT CONTRACEPTION USE 
 
Many women had previously used injectable progestogens (71 cardiac and 83 
hypertensive women), COC (28 cardiac and 33 hypertensive women), male condoms 
(29 cardiac and 19 hypertensive women) and IUCD (5 cardiac and 3 hypertensive 









FIGURE 4: PREVIOUS CONTRACEPTION USE 
 
Most women received contraception from family planning clinics (29 cardiac and 36 
hypertensive women) or a Day Hospital (12 cardiac and 22 hypertensive women).  Two 
cardiac women and 5 hypertensive women accessed contraception from more than one 
source. None of the women received contraception at their cardiac or hypertension 
clinics (Table 10). Some women felt that contraceptive services were not user-friendly 
(20 cardiac and 33 hypertensive), and not accessible (8 cardiac and 13 hypertensive). 
 
TABLE 10: SOURCES OF CONTRACEPTION FOR PARTICIPANTS 
  CARDIAC HYPERTENSIVE 
FAMILY PLANNING CLINIC 29  36  
DAY HOSPITAL 13  22 
GENERAL PRACTITIONER 4  3  
CARDIAC/HYPERTENSION 
CLINIC  0  0 
PHARMACY 6  5  
OTHER HOSPITAL SERVICES 1  0  
OTHER 5  1  
PREVIOUS STERILIZATION 29  20  
NO CONTRACEPTION 15  18  






Even though 71/100 cardiac and 75/100 hypertensive women felt comfortable about 
possibly discussing contraception at their respective clinics, only 29 cardiac and  23 
hypertensive women had received contraceptive advice at the clinics. Fifty two cardiac 
and 67 hypertensive women reported never to have received contraceptive advice from 
their medical clinics. Fifty two cardiac and 59 hypertensive patients reported that they 
would like the doctors or nurses in their medical clinics to give them information 
regarding contraception.  
 
Women who were diagnosed with hypertension more than 10 years previously were 
more likely to be advised against pregnancy and offered sterilisation (Wilcoxon-Mann-
Whitney U-test p<0.001). This correlation was not observed in the cardiac group. 
Twenty three of 25 cardiac women, and 10 of 15 hypertensive women who were 
advised to consider sterilisation by health care workers had not elected to have the 
procedure. 
OBSTETRIC HISTORY 
Table 11 reports the gravidity of the women in both groups. Sixteen cardiac and 10 
hypertensive women had never been pregnant. 
TABLE 11: GRAVIDITY OF WOMEN IN BOTH GROUPS 
GRAVIDITY CARDIAC HYPERTENSION 
0 16 10 
1 24  11 
2 30 24  
3 17  34  
4 10  10 
5 2  7  
6 1  2 
7 0  2  
Total 100  100  
 
Mean age at first pregnancy among cardiac and hypertensive participants were 22.52 






TABLE 12: AGE AT FIRST PREGNANCY 
  Min.    1st Qu. Median  Mean    
3rd 
Qu. Max.    
CARDIAC 14.00 20.00 21.00 22.52 25.00 37.00 
HYPERTENSION 13.00 18.00 20.00 20.60 23.00 29.00 
 
The total number of pregnancies among cardiac women was 193, with 21 miscarriages, 
3 social TOPs and 1 ectopic pregnancy.  Four women had stillbirths, and there were no 
early neonatal deaths. The total number of surviving children was 167. The total 
number of pregnancies among hypertensive women was 262, with 38 miscarriages, 14 
stillbirths and 6 early neonatal deaths. None of the hypertensive patients had a history 
of TOP or ectopic pregnancy. There were 206 surviving children in the hypertension 
group.  
 
Ninety eight of 193 pregnancies among cardiac women had maternal complications 
which included hospital admissions (n=5), ICU admissions (n=16), pulmonary edema 
(n=10), arrhythmia (n=10), pre-eclampsia (n=10), haemorrhage (n=8), and thrombo-
embolic events (n=5). 
 
 Maternal complications among women with hypertension occurred in 165 of 262 
pregnancies and included hospital admissions (n=76), ICU admissions (n=15), kidney 
failure (n=4), pre-eclampsia (n=5), abruption (n=4). Other complications among the 
hypertensive group included anemia (n=3), eclampsia (n=1), stroke (n=1), pulmonary 
edema (n=1), gestational diabetes (4), infection (n=2), blindness (n=1), unspecified 
(n=3). A longer duration of the medical condition significantly correlated with the 
occurrence of maternal complications in both cardiac (Wilcoxon p=0.036) and 
hypertensive women (Wilcoxon-Mann-Whitney U-test p<0.001).  
 
The timing of diagnosis of the medical conditions varied and is shown in Table 13. The 





women diagnosed with hypertension for the first time during pregnancy than cardiac 
women (n=42 vs 18, Fisher’s Exact test p<0.001). 
TABLE 13: TIMING OF DIAGNOSIS IN RELATION TO PREGNANCY 
  CARDIAC HYPERTENSION 
DIAGNOSED DURING PREGNANCY 18  41  
DIAGNOSED AFTER PREGNANCY 52 40 
DIAGNOSED BEFORE PREGNANCY 14  9  
TOTAL 84  90  
 
Contraception was reported to have been offered to cardiac and hypertensive women 
after 164 of 193 and 216 of 262 pregnancies respectively. One cardiac and no 
hypertensive patient declined the offer of contraception. Eight cardiac and 8 
hypertensive patients stated that they were not offered contraception after any of their 
pregnancies. 
 
Women diagnosed with cardiac disease before pregnancy were less likely to be offered 
contraception in the post-partum period than women diagnosed after pregnancy (n=8, 
57% cardiac before pregnancy, n=46, 88% diagnosed after pregnancy), however  this 
was not statistically significant (Fisher’s Exact test p=0.06). In the hypertension group, 
contraception was offered more frequently to women who were diagnosed before 
pregnancy (n=8, 89%) than those diagnosed after pregnancy (n=31, 77%), but this was 
also not statistically significant (Fisher’s Exact test p=0.08).  
 
After delivery cardiac patients were most frequently offered injectable progestogens 
(n=49) followed by sterilisation (n=17), COC (n=13) and progestogen only pill (n=10). 
Postpartum hypertensive women were most frequently offered injectable progestogen 
(n=67) followed by sterilisation (n=14), progesterone only pill (n=10) and combined 
oral contraception (n=6). Condoms for contraception were reported to have been 





FIGURE 5: CONTRACEPTION OFFERED AFTER PREGNANCY 
 
Sixty one cardiac (72%) and 63 hypertensive (70%) women had at least one unplanned 
pregnancy. The number of unplanned pregnancies was 120/192 in cardiac and 
132/262 in hypertensive groups. There was no statistical difference in age distribution 
(Wilcoxon-Mann-Whitney U-test p=0.214 in cardiac and p=0.297 in hypertension), 
emotional support (Fisher’s Exact test p=1.000 in cardiac and p=0.551 in hypertension), 
knowledge of contraception (Fisher’s Exact test p=1.000 in both groups) or education 
(Fisher’s Exact test p=0.553 in cardiac and p=0.390 in hypertension) between planned 
and unplanned pregnancies. In the cardiac group, there was no association between 
employment and planning of pregnancy (Fisher’s exact test p=0.403).  
 
In the hypertensive group, unemployment was associated with unplanned pregnancies 
as 81% of unemployed women had unplanned pregnancies compared to 65% of 
working women (Fisher’s Exact test p= 0.03).  
 
Some of the reasons given by the participants for unintended pregnancy included lack of 
contraceptive knowledge (n=33 cardiac, n=9 hypertensive), contraception failure (n=17 
cardiac and n=13 hypertensive), discontinuation of contraception due to side-effects 
(n=13 cardiac and n=18 hypertensive women), and delay in obtaining contraception 





using contraception and 4 stated that they were advised against contraception because 
of their medical condition. 
 
MEDICAL HISTORY OF CARDIAC GROUP 
The mean age at first diagnosis of cardiac disease was 21 years (range 1.0-43.00) (Table 
14). The mean duration of disease was 12 years (range 0.33-39.58).   
 
TABLE 14: AGE AT FIRST DIAGNOSIS OF CARDIAC DISEASE 
  Min.    1st Qu. Median  Mean    
3rd 
Qu. Max.    
CARDIAC 1.00 11.00 23.00 21.81 32.25 43.00 
 
The most common cardiac pathology was rheumatic heart disease with a total of 50 
patients. Thirty three of these women had valve replacement surgery (n=28, on 
warfarin), and 17 had not. There were 21 cardiomyopathies (n=2, cardiac arrythmias), 
14 congenital heart disease (n=4, corrected surgically), isolated cardiac arrhythmia (n= 
12), 4 ischemic heart disease (n=1, with cardiac arrhythmia), 1 Takayashu’s disease, 1 
arteriosis, 1 aortic dissection with surgery (Figure 6). Forty six percent of the women 
had a family history of cardiac disease. 






Eighty seven women were on medication for cardiac disease. The mean duration of 
treatment was 11 years (IQR 2.58-22.96).  The most commonly used medications 
included diuretics (54/100), warfarin (51/100), B-blockers (46/100), and ACE-
inhibitors or angiotensin receptor blockers (30/100) (Figure 7). Only 4 patients were 
not on any medication.  
 
FIGURE 7: MEDICAL TREATMENT FOR CARDIAC GROUP  
 
 
Forty cardiac patients had co-morbidities which included hypertension (n=16), HIV 
(n=9), and stroke (n=3). Twenty one had other medical conditions included Marfans 
Syndrome(1), lymphoma (n=2), asthma (n=4), musculoskeletal conditions (n=7), 
gastro-oesophageal reflux (n=3), major depressive disorder (n=1) , Noonan syndrome 
(n=1) and epilepsy (n=1). The longer the duration of cardiac disease, the more frequent 
were co-morbidities (p=0.036). There were only 3 cardiac women interviewed who 
were attending the clinic for the first time. Most of the participants were regular 









FIGURE 8: NUMBER OF SCHEDULED VISITS PER YEAR IN CARDIAC GROUP 
 
 
MEDICAL HISTORY OF HYPERTENSION GROUP 
The mean age at first diagnosis of hypertensive patients was 29.26 years (range from 
youngest to oldest 13.00-44.00 years) (Table 15). The mean duration of disease was 7 
years (range 0.17-32.92 years).  
TABLE 15: AGE AT FIRST DIAGNOSIS OF HYPERTENSION 




13.00 24.00 29.50 29.26 35.25 44.00 
 
There were 55 women with co-morbidities. These included HIV (n=11), diabetes (n=9), 
renal disease (n=5), cardiac disease (n=4), and stroke (n=3). Unlike the cardiac group, a 
longer duration of hypertension was not associated with the presence of co-morbidities 
(Wilcoxon p=0.755). Family history of hypertension among the hypertensive women 
was significantly higher than the family history of cardiac disease in the cardiac group 
(81% vs 46%, Fisher’s test p<0.001). All the hypertensive participants were on 
treatment. The patients had been on medication for an average of 5 years (IQR 2.08-
19.7). Many participants were on diuretics (80), calcium channel blockers (71), ace-







FIGURE 9: MEDICAL TREATMENT FOR HYPERTENSIVE GROUP 
 
There were only 5 hypertensive women interviewed who were attending the clinic for 
the first time. Most of the participants were regular attenders with at least one 
scheduled visit per year (Figure 10). 










MEDICAL AND REPRODUCTIVE KNOWLEDGE 
When asked to mention complications from cardiac disease and hypertension, 62 
cardiac and 82 hypertensive women mentioned at least one of the recognised 
complications (Fisher’s exact test p=0.03). The complications mentioned in the cardiac 
group were heart failure (26) and stroke (24), and in the hypertensive group, stroke 
(64), cardiac disease (37), renal disease (13), retinopathy (5), malignant hypertension 
(4) and pregnancy complications (3) (Table 16).  
 
TABLE 16: KNOWLEDGE OF MEDICAL COMPLICATIONS IN BOTH GROUPS 
 
CARDIAC HYPERTENSION 
KNOWLEDGE OF  COMPLICATIONS 
MENTIONED NOT MENTIONED MENTIONED 
NOT 
MENTIONED 
CARDIAC DISEASE - - 37  63  
RENAL DISEASE - - 13  87  
RETINOPATHY - - 5  95  
PREGNANCY COMPLICATIONS - - 3  97  
MALIGNANT HYPERTENSION - - 4  96  
STROKE 24  76  64  36  
NONE VOLUNTEREED 38  62  18  82  
OTHER 19  81 30  69  
HEART FAILURE 26  74  - - 
NEED FOR HEART SURGERY 8  92 - - 
INFECTIVE ENDOCARDITIS 1  99 - - 
HEART ATTACKS 11  89  - - 
PREGNANCY WOSENS HEART  10  90  - - 
ARRYTHMIAS 2 98  - - 
 
Patients were asked to volunteer information, without prompting, on how cardiac 
disease or hypertension could adversely affect pregnancy and 56 cardiac and 48 
hypertensive women were not aware of any possible complications. The most common 
pregnancy complications mentioned in the cardiac group were stillbirths (n=13), 
congenital abnormalities (n=11) and fetal growth restriction (n=10). Others mentioned 
preterm births (n=5), TOP as result of cardiac disease (n=5), bleeding from medication 






Hypertensive patients mentioned the following complications: still births (n=29), 
miscarriages and TOP (n=12), and preterm births (n=11), maternal death (n=7), 
congenital abnormalities (n=7), and seizures (n=4).  
 
Education level, employment status, and emotional support did not influence 
knowledge of pregnancy complications from cardiac disease and hypertension among 
the participants of this study. 
 
Patients were then asked how pregnancy could affect cardiac disease or hypertension. 
Some cardiac (n=38) and hypertensive (n=55) women could not give an answer 
(Fisher’s Exact test p=0.023). Cardiac participants mentioned worsening cardiac disease 
(n= 49), death (n= 9), bleeding from warfarin (n= 2), need to change medication (n=2), 
arrhythmias (n= 2). Hypertensive participants mentioned worsening of hypertension 
(n= 28), death (n=3), pre-eclampsia (n= 3) and worsening of kidney disease (n= 3). The 
age of participants, emotional support, education, employment, previous maternal 
complications, family history of medical conditions and number of clinic visits were not 
associated with knowledge of impact of pregnancy on medical conditions in either 
group. 
 
Cardiac and hypertensive women were asked, without prompting, to mention all 
contraceptive methods they knew about. Ninety nine cardiac and 99 hypertensive 
women mentioned at least one modern contraceptive method. The one cardiac woman 
who failed to mention any method had never been sexually active and had never used 
contraception. The one hypertensive woman who also failed to mention contraceptive 








The most known contraceptive methods in the cardiac group were injectable 
progestogens (n=90), COC (n=66), male condoms (n=53), intrauterine contraceptive 
device (n=32), female sterilisation (n=15) and minipill (n=11). Male sterilization (n=4), 
Mirena (n=4) and long-term implants (n=1) were infrequently mentioned.  
 
Hypertensive women mentioned injectable progestogens (n=91), COC (n=74), male 
condom (n=45), IUCD (n=36), female sterilization (n=23) and the minipill (n=9). Male 
sterilization was mentioned by 3 hypertensive women. Mirena and long-term implant 
were not mentioned by the hypertensive women (table 17). 
 
TABEL 17: KNOWLEDGE OF CONTRACEPTION 
 
CARDIAC HYPERTNSION 
COC 66 74  
MINIPILL 11 9  
INJECTABLES 90  91  
IUCD 32  36  
MIRENA 4  0  
CAP 2  1  
MALE CONDOM 53  45  
FEMALE CONDOM 16  12  
IMPLANT 2  1  
RHYTHM METHOD 1 2  
WITHDRAWAL 2  1  
ABSTINENCE 4  1  
SPERMICIDE 1  0  
FEMALE 
STERILIZATION 15  23  
MALE 
STERILIZATION 4  3  
MORNING AFTER 
PILL 1  1  
NONE OF THE ABOVE 1  1  
PATCH 1  0  
 
Some women felt that there was insufficient information regarding pregnancy and their 
medical condition (n=47 cardiac and n=56 hypertensive), or about contraception and 





cardiac and 74 hypertensive participants mentioned that they would like to receive 
additional information regarding pregnancy and contraception specific to their medical 
condition during their medical consultation. Many women suggested booklets (n=36 
cardiac, n=35 hypertensive), individual counselling sessions (n=17 cardiac, n=20 
hypertensive), group talks (n=13 cardiac, n=14 hypertensive), posters (n=4 cardiac, n=6 
hypertensive), and videos (n=2 cardiac, n=5 hypertensive) as ways of delivering 
information regarding reproductive health.   
 
Women also mentioned local clinics (n=25 cardiac and n=25  hypertensive), family 
planning clinics (n=19 cardiac and n=16 hypertensive), family doctors (n=7 cardiac, n=5 
hypertensive) and relatives (n=8 cardiac and n=7 relatives) as other trusted sources 


















SUMMARY OF RESULTS 
 Many women in both groups had first coitus as teenagers at least one year before 
initiating contraception. 
 Eighty four cardiac and 90 hypertensive women had previous pregnancies 
 72% of cardiac and 70% of hypertensive women had at least one unplanned 
pregnancy. Age, emotional support, education, housing, knowledge of 
contraception did not have an impact on unintended pregnancy. Among 
hypertensive women unemployment was associated with unintended pregnancy. 
 Injectable progestogens, female sterilisation and male condoms were the most 
used contraception. However only 18 cardiac and 11 hypertensive women used 
condoms. There were 25 cardiac and 27 hypertensive women who were not 
using any contraception.  
 Most women accessed contraception from family planning clinics and day 
hospitals. None of the women accessed contraception from their medical clinics. 
 Many women reported that they had never received contraceptive advice from 
their medical clinics. They felt that information about their medical conditions 
and reproductive health was limited. Some women who were advised to 
consider bilateral tubal ligation had not agreed to the procedure. 
 Knowledge of contraceptive methods was high, however there was limited 
knowledge and use of long-term reversible contraception such as IUCD and 
Mirena. 
 Knowledge of the impact of medical disease on pregnancy, and the impact of 
pregnancy on medical disease was limited in both groups, even in the women 
who had previous complications related to the medical conditions in their 
pregnancy. 
 The majority of women reported that they would like their physicians to discuss 





they would like to receive additional information on reproductive health in the 

























CHAPTER 4: DISCUSSION 
This study showed that despite the relatively high contraceptive knowledge, current 
and previous contraception use, most women with significant cardiac and hypertensive 
disease who were interviewed still had unplanned pregnancies.  Knowledge of the 
impact of their medical condition on reproductive health was lacking. Women were also 
not advised on reproductive health issues and were not accessing contraception at their 
medical clinics. Many women indicated that they would appreciate receiving 
contraceptive advice which impacted on their medical conditions. 
 
Despite the burden of poor maternal and perinatal outcome in women with pre-existing 
medical conditions, and high contraceptive knowledge among participants, 72% of 
cardiac and 70% of hypertensive women in our study had at least one unintended 
pregnancy. The finding was significantly higher than the rate found in South African and 
Kenyan studies that investigated the prevalence of unintended pregnancy among 
women (59.7% SA study39, 24% Kenyan study49). In contrast to our study, a 
community-based study conducted in Kenya found significant association between age 
and type of settlement and unintended pregnancy.  Similar to the Kenyan study, 
hypertensive women who were married or employed were more likely to plan their 
pregnancy compared to unmarried and unemployed hypertensive women. There was 
no association between marital and employment status and unintended pregnancy 
among the cardiac women. 
 
 
Women who were attending family planning clinics in a North American multi-centre 
study had stated they were not using contraception because it was not accessible 
(49%), they were not planning on having sex (45%) and sex felt better and more 
natural (42% and 41%).40 There were no women interviewed in our study who 
expressed these views.  
 
The majority of women in our study initiated coitus in their teenage years, and at least 





teenage pregnancy and pregnancy complications. Mean age at first intercourse in 
SADHS14 was similar to our study (18.5 years in SADHS vs 19.1 years in cardiac and 18.1 
years hypertensive), however the SADHS did not investigate age at first contraception. 
 
In a study conducted in Potchefstroom, South Africa, investigating contraception use 
and unintended pregnancy, Bafana found that the commonest reason for unintended 
pregnancy was discontinuation of contraception due to side-effects (33%).39 In our 
study, 13% of cardiac and 18% of hypertensive women had unintended pregnancies 
after discontinuation of contraception due to side-effects.  
 
We did not investigate further details about the unacceptable side-effects the women 
had experienced and which resulted in discontinuation of contraception and 
unintended pregnancies. In our study and SADHS, injectable progestogens have always 
been and still are the most common contraceptive method used by women. It is known 
that injectable progestogens often result in irregular bleeding and amenorrhoea which 
may not be acceptable to some women.  
 
A multicentre study showed that a significant number of women preferred to have 
periods as reassurance of non-pregnant state and to “get rid of old blood”.50 in a South 
African study conducted in Limpopo Province, adolescent girls interviewed on barriers 
to access to contraception also reported that menstrual irregularities and amenorrhoea 
caused many of them to discontinue contraception. This was because absence of 
menstruation caused uncertainty about pregnancy status, and resulted in myths about 
“blood blockage” caused by contraception that resulted in multiple symptoms.41  
 
Knowledge and use of some effective long-acting reversible contraceptives such as IUCD 
and IUS (Mirena) was limited. Our study showed no improvement in the knowledge of 
these contraceptive methods compared to a study conducted in Cape Town 6 years ago. 
In the prior study 46% of women (vs 32 % cardiac and 36 % hypertensive) had some 





(Mirena).52 Only 4 women used IUCD and Mirena, which is unfortunate because of the 
missed benefit of avoiding side-effects experienced by injectable progestogen users. At 
the time of the study, Implanon had not yet been introduced to the public sector. Only 1 
patient had heard of it.  
 
In a country with a high burden of HIV, condom use, current and previous, was very low. 
This is concerning given the very dynamic educational programmes South Africa has 
invested in to reduce HIV transmission. Only 18 cardiac and 11 hypertensive women 
reported currently use a condom despite 69 cardiac and 57 hypertensive women 
mentioning it as contraceptive method they knew about. Five of 9 cardiac and 5 of 11 
hypertensive women who were HIV positive did not currently use condoms. In the 
SADHS 2003 report, 70.9% of participants reported that they used condoms.14 
 
The majority of women in our study belonged to Christian and Islamic religion. There 
was only one out of 200 women who had not used contraception and had unintended 
pregnancies because her religion prohibited contraception use. In a KAP (knowledge, 
attitude and practice) study of contraception in Pakistan, 65% of women interviewed 
believed that religion prohibited contraception use but many women knew about 
contraception and had used it at some point.51 
 
The relatively high knowledge of contraceptive methods in both our surveyed groups 
(99%) was comparable to the finding of SADHS (94% of women).14 Women over time 
have acquired some contraceptive knowledge. Lack of contraceptive knowledge at the 
time of conception was mentioned as a cause of unintended pregnancy by 33 cardiac 
and 9 hypertensive women. Only one patient who had previously had an unintended 






Post-partum contraceptive uptake was reported to be high among the participants. It 
was surprising that some cardiac women with pre-existing cardiac disease reported 
that they were not offered any contraception following the pregnancies. 
 
Despite the high knowledge, there were still 25 cardiac and 27 hypertensive women in 
our study  who were not currently using any contraception and were therefore at risk of 
unplanned pregnancy.  Some women who reported that they had been advised to 
consider tubal ligation had not agreed to the procedure. We did not investigate the 
reasons for not doing so. We also did not enquire about desire for fertility in the future. 
 
 In a study to assess attitude towards contraception in University of Natal, most 
students knew about contraceptive methods, but underestimated the effectiveness of 
contraception in preventing pregnancies, and did not believe that unprotected 
intercourse could result in pregnancy. Contraception use was associated with the 
stigma of promiscuity by the students.42In our study, we did not elicit any such stigma 
associated with contraception. 
 
Complications of the medical conditions in both groups were better known than 
pregnancy complications secondary to their medical condition (n=62 cardiac n=82 
hypertensive group vs n= 38 cardiac and n=55 hypertensive women). We did not 
enquire whether patients were given information regarding their medical conditions 
from the clinic and it is therefore not possible to conclude that their knowledge of 
medical complications was from information sharing with health care workers at their 
clinics.  
 
Knowledge of pregnancy complications was not influenced by previous pregnancy 
complications.  We would have expected that if patients had previous complications in a 
pregnancy, they would have been thoroughly counselled about their medical condition 





counselling these high risk women receive from the attending obstetricians and their 
retention of information. 
 
Many patients mentioned that they had never been educated about contraception, 
reproductive health issues and their medical condition, and that there was insufficient 
information available regarding pregnancy and their medical conditions. A Canadian 
study that investigated contraception education given by medical doctors to women 
with congenital heart disease revealed that 50% (n=9) of women with WHO class 4 
cardiac disease did not recall being advised against pregnancy despite documentation of 
such advice in their medical records.53 The majority of women in our study were in 
contact with health care professionals at least once a year. Opportunities are available 
to re-enforce reproductive health education to these high risk women. 
 
Patients overall felt that contraceptive services were readily available. There were no 
patients who received contraception from their medical clinics. Such clinics do not 
usually serve this purpose, and only 3 patients felt that they would be a convenient site 
to access contraception. It would theoretically be convenient for patients to get 
contraception and contraceptive advice on the same visit at their medical clinics, 
however it could be logistically challenging to set up such a service at the busy medical 
clinics.   
 
Patients are not always satisfied with the advice from their care givers. A study 
conducted in Switzerland showed that 68.6% of women with hypertensive disorder of 
pregnancy were dissatisfied with medical information from their health care givers.54 
They reported to have not received any information (34.8%), suspected that the doctors 
had limited knowledge (24.6%) or were given incomplete information (15%).  Perhaps 
health care workers need to find ways to improve information sharing with their 
patients.  Many women suggested various methods of delivering information about 







Medical conditions such as cardiac disease and hypertension can result in maternal and 
perinatal morbidity and mortality. These pregnancies require close surveillance and 
medical expertise.  Contraception is key in reducing the burden of pregnancy 
complications from the medical conditions. The National Committee for Confidential 
Enquiry into Maternal Death (NCCEMD) recommends that all women with pre-existing 
medical conditions must be advised about contraception. Family planning services are 
widely available in the public healthcare sector, and offer a wide variety of 
contraceptive methods free of charge. 
 
Our study showed that majority of women with cardiac disease and hypertension had 
unintended pregnancies. Knowledge of pregnancy complications from medical 
conditions was limited. Many women have never received reproductive health 
information from their medical clinics, and none of the women access contraception 
from these clinics. 
 
Current contraception use was high but there was limited use of barrier methods 
including among those who were known to be HIV positive. There was also limited use 
of other effective contraceptive methods such as IUCD and Mirena. 
 
The opportunity to discuss reproductive health issues with the high risk women is 
always available as many women attend their clinics at least once a year. Many women 
would like their physicians to discuss contraception and pregnancy during their visits to 
the clinic. They would also like to receive additional information in the form of reading 
material and group talks. Reproductive health education should be part of holistic care 
of women in general. It is the responsibility of all health care workers who consult with 
these high risk women to make an effort and provide them with reproductive health 
information, or refer them in order to enable them to make informed decisions 
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APPENDIX 1: HUMAN RESEARCH ETHICS COMMITTEE 












































REPRODUCTIVE AND CONTRACEPTIVE 
KNOWLEDGE AMONG WOMEN WITH 
HYPERTENSIVE AND CARDIAC DISEASE 







Patient Number:      _____________________ 
Date of Interview:   _____________________ 
Place of Interview:  _____________________ 







1. Date of Birth 
 
 
2. Age (in years and months) 
 
 
3. Population Group  




(5) Foreign African (please specify) 
(6) Foreign Non- African (please specify) 
(7) Other (please specify) 
 
 





(5) Other (please specify) _________________________________________ 
 
 








(3) Roman Catholic 
(4) Christian Other (please specify)  ________________________________ 
(5) Hindu 
(6) Jewish 












RELATIONSHIP STATUS AND SUPPORT 
7. Marital Status 
(1) Single, not in a relationship 
(2) Single in a stable relationship but not cohabiting 






8. From whom do you receive financial support? (Mark all that apply) 
(1) Self 
(2) Partner/ Husband 
(3) Parent/s 
(4) Sibling/s 
(5) Other Relative/s (please specify)  ______________________________ 
(6) Friend/s 
(7) Disability Grant 
(8) Child Support Grant 
(9) No Financial Support 
(10) I don’t know 
 





(5) Other relatives (please specify)  _______________________________ 
(6) Friend/s 
(7) Other (please specify)  ______________________________________ 
(8) No Emotional Support 








10. Highest Level of Education 
(1) No formal schooling                               (9) Grade 8 
(2) Grade 1                                                     (10) Grade 9 
(3) Grade 2                                                     (11) Grade 10 
(4) Grade 3                                                     (12) Grade 11 
(5) Grade 4                                                     (13) Grade 12 
(6) Grade 5                                                     (14) Tertiary (incomplete)                                                
(7) Grade 6                                                     (15) Tertiary (complete) 











11. Employment Status 
(1) Unemployed 
(2) Self Employed 
(3) Employed (Casual) 
(4) Employed (Formal) 
(5) Student/Scholar 
(6) Housewife 
(7) Disability or Other Grant 
(8) Other (please specify)  _______________________________________ 
 
 
12. What is your job? 
(1) N/A – unemployed 
(2) Housewife 
(3) Domestic Worker 
(4) Factory Worker 
(5) Office Worker 
(6) Professional 




13. Type of Dwelling 
(1) Formal house on separate stand 
(2) Flat 
(3) Semi-detached house 
(4) Separate entrance (room in main dwelling) 
(5) Wendy house (room in backyard) 
(6) Informal Dwelling/Shack 
(7) Room in main dwelling 
(8) Homeless 
(9) Other (please specify) 
 
 
14. Do you own your own home? 
(1) YES 
(2) NO  
(3) N/A 








15. Do you smoke cigarettes? 
(1) YES 
(2) NO, never 
(3) STOPPED less than 6 months ago 
(4) STOPPED more than 6 months ago 
 
16. If YES how many cigarettes a day? 








17. Do you consume alcohol? 
(1) YES 
(2) NO, never 
(3) STOPPED less than 6 months ago 
(4) STOPPED more than 6months ago 
(5) N/A 
 
18. If YES, how many units/week? 
1 unit of alcohol = 1 glass of wine, a nip or 1 shot of spirit, 1 glass of beer 
(~200mls) 
<1 = infrequent use) 





19. Do you use any recreational drugs? 
(1) YES 
(2) NO, never 
(3) STOPPED less than 6 months ago 
(4) STOPPED more than 6 months ago 
 






(6) Other (please specify) 










21. Age of  first coitus 
 
 
22. Age of first contraception  
 
 
23. Age of menarche 
 
 




If NO, proceed to Question 53 (ie. omit questions 25 – 52) 
 
 





































































1.       
2.       
3.       
4.       
5.       
6.       
7.       
8.       
9.       






























  37.  What contraception were you offered after pregnancy? (Must volunteer, 
      mark all that apply) 
(1) Male condoms 
(2) Female condoms 
(3) Combined Oral Contraceptive Pill 
(4) Progesterone Only Pills 
(5) Injectable Contraceptives (progestagens) 
(6) Intrauterine contraceptive Device 
(7) Intrauterine system 
(8) Sterilisation  
(9) Other (please specify) 
(10) N/A (not offered any method) 
(11) N/A never been pregnant 
 
       38.  What was the reason for the TOP? 
(1) Maternal complications due to cardiac disease 
               (2) Maternal complications not related to cardiac disease 
               (3) Fetal complications/abnormality 
               (4) Socio-economic reasons 
               (5) Unintended pregnancy 
               (6) N/A (no previous TOP) 
 
 


































































(3) Don’t  
know 
1.        
2.        
3.        
4.        
5.        
6.        
7.        
8.        
9.        






























46. How many surviving children do you have? (give number) 
 
 
47. Were you diagnosed with cardiac disease for the first time in any pregnancy  
 (including puerperium)? 
(1) Yes 
(2) No 
(3) I don’t know 
(4) Already been diagnosed with cardiac disease before pregnancy 
(5) Diagnose after pregnancy 
 
 
48.  If yes in 47, which pregnancy? –list all. 




49.  If yes in 47, did your symptoms resolve after pregnancy? 
(1) Yes, returned to normal after all the pregnancies 
(2) Yes, returned to normal after some but not all the pregnancies 
(3) Never returned to normal 
(4) N/A 
(5) Don’t Know  
 
50.  Were all your pregnancies planned? 
(1) YES 
(2) NO 
(3) I can’t remember/I don’t know 
 
 
51.  Were you using any form of contraception when you conceived? 
(1) YES (Specify which pregnancy)________________________________ 
(2) NO 
(3) I can’t remember/I don’t know 
(4) I have never been pregnant 
(this applies to all pregnancies) 
 
52.  What was the reason if “No” in 51? (Must volunteer) 
(1) Planned Pregnancy 
(2) Did not think I could get pregnant because cardiac disease made it more 
difficult to conceive 
(3) Previously had not conceived despite not using any contraception 
(4) Previously not conceived despite fertility treatment 
(5) Hoping to fall pregnant although not actively planning it 
(6) I accidentally delayed getting my scheduled contraception 
(7) I stopped contraception because of side effects 
(8) Partner convinced me to stop contraceptive 
(9) Doctors asked me to stop contraception for medical reasons 
(10) Partner said he was sterile 
(11) Contraception difficult to access 
(12) I was sterilised 
(13) N/A I was on contraceptives 










MEDICAL HISTORY [ALSO FROM NOTES] 
53.  Is there anyone in your family with heart disease 
(1)  Yes 
(2)  No 
(3)  I don’t know 
 




55.  At what age were you started on treatment? 
 
56.  Current Treatment 
 YES NO Don’t Know 
(1)Diuretics - e.g: Lasix    
(2) Beta blockers -e.g: Atenolol    
(3)Ace-inhibitors -e.g: Enalapril, 
Angiotensin Receptor blockers-
e.g: Losartan 
   
(4)Calcium channel blockers -
e.g: Verapamil, Amlodipine, 
Adalat XL 
   
(5)Anticoagulants -e.g: Warfarin    
(6)Antiplatelets- e.g: Aspirin    
(7)Anticholesterol - e.g: Statins    
(8) Antiarrythmics -e.g: Digoxin    
(9)Trinitrates for angina -e.g : 
Isordil 
   
(10)ARV’s     
(11)Other-specify___________ 
 










57.  Do you have any other medical problems?  
(1)Yes 
(2) No 
(3) I do not know 
 
 




(4) Previous thrombo-embolic disease 
(5) Kidney disease 
(6) HIV 
(7) Other (specify)   ___________________________________________ 
(8) I do not know 










59.  Number of scheduled visits to cardiac disease clinic per year 
(1) 2 or less 
(2) 3 or more 
(3) Referred to Day Hospital or similar 
(4) First visit 
 
 
      59 (a). Nature of cardiac disease (from patient and folder) 
 
DIAGNOSIS YES NO NOT SPECIFIED 
1.Cardiomyopathy    
2.Rheumatic Heart disease 
without valve replacement 
   
3.Rheumatic Heart disease with 
valve replacement 
   
4.Congenital Heart Disease    
5.Cardiac arrythmia    
6.Ischaemic Heart Disease    
7. Other cardiac surgery  
(specify)__________________ 
   
8.Other cardiac disease  
(specify)__________________ 
   














60.  What complications have you been told can occur secondary to cardiac  
disease? 
(must volunteer, tick yes if mentions) 
      YES 
(1)Heart failure  
(2)Need for heart surgery  
(3)Infective endocarditis  
(4)Stroke  
(5)Heart attacks  
(6)Pregnancy could worsen the heart condition  
(7)Arrythmias  
(8)Other (please specify)  _________________________  
(9) None volunteered  
 
 
61.  Do you understand how cardiac disease can affect a pregnancy? 
(must volunteer, tick yes if mentions) 
    YES 
(1) Growth restriction  
(2) TOP because of worsening 
heart condition 
 
(3) Preterm birth  
(4) Congenital Abnormality  
(5) Stillborn  
(6)Caesarean Section  
(7)Haemorrhage from meds  
 (8)Other (please specify)  



















62.  Do you know if pregnancy affects cardiac disease in any way? 
(must volunteer, tick yes if mentions)  
 
    YES 
(1)Worsens cardiac disease  
(2)Thrombo-embolism  
(3)Need to change medication  
(4)Need for emergency heart 
surgery and ICU care 
 
(5)Induce or worsen arrythmias  
(6)Other (please specify)  
(7)None volunteered  
 
 
63. Have you received any contraception/family planning/pregnancy   
planning/contraceptive advice at your cardiac clinic? 
(1) YES 
(2) NO 








64.  Do you feel comfortable asking your cardiac doctor/sister for advice? 
(1) YES 
(2) NO 






65.  If NO, why not? 
(1)Clinic too busy  
(2)Doctor/Sister too rushed  
(3)Doctors and nurses have never initiated the topic  
(4)Shy/Uncomfortable to initiate topic with doctor/sister  
(5)Doctor/sister not interested  
(6)Did not think to ask anyone  
(7)Thought this “belonged” elsewhere in the service  
(8)N/A – Received advice/referral  














66.  Who would you ask for contraceptive advice? 
(1)Parents  
(2)Friends  
(3)Family doctor  
(4)Local Clinic Doctor/Sister  




(9)Family Planning Clinic  
(10)Other Relatives  
(11)Other (please specify)  
























(3) Don’t Know 
 
 
68.  Do you find it easy to access contraception? 
(1) YES 
(2) NO 
(3) I don’t know(never tried) 
 
 
69.  Where do you usually get contraception? 
(1) Family planning clinic 
(2) Day hospital 
(3) Family doctor/GP 
(4) Diabetic Clinic 
(5) Pharmacy 
(6) Other hospital services 
(7) Other (please specify)   ______________________________________ 
(8) Previous sterilisation 
































70.  Please list all the methods of family planning which you KNOW ABOUT? 
[SPONTANEOUS INPUT] 
 
  71. I will now ask you to list all methods you have ever USED.  [SPONTANEOUS    
INPUT] 
 
72.  Which method are you CURRENTLY USING? [SPONTANEOUS INPUT] 
 
 
METHOD 70. KNOW ABOUT 71. USED BEFORE 72. CURRENTLY USING 
a] Pill (COC)    
b] Mini pill (POP)    
c] Injection (Depo)    
d] Loop (IUCD)     
e] IUS (Mirena)    
f] Cap/Diaphragm     
g] Male condom    
h] Female Condom    
i] Long term implants    
j] ”Rhythm” method    
k] Withdrawal method    
l] Abstinence    
m] Spermicides    
n] Female sterilisation    
o] Male sterilisation    
p] Morning after pill     
q]Termination/abortion    
r] none of the above    
s] other (please specify)    






76.  Have you been given a choice of family planning which was suitable for you? 
(1) YES 
(2) NO 




77.  Do you understand that some contraception will not be suitable for you 
because of your cardiac condition? 
(1) Yes 
(2) No 
(3) I do not know 
 
78.  Do you feel information regarding contraception and cardiac disease is 
readily available to you? 
(1) YES 
(2) NO 
(3) I don’t know 
 
79.  Do you feel there is enough information regarding pregnancy and cardiac 
disease available to you? 
(1) YES 
(2) NO 
(3) I don’t know 
 
 
80. Do you feel that the contraception services available to you are adequate  
and user friendly? 
(1) YES 
(2) NO 




81. Would you value more information regarding contraception, reproductive 
and women’s health specific to cardiac disease? 
(1) YES 
(2) NO 
(3) I don’t know 
 
82.  If YES, how or where would you like to receive this advice? 
(1) N/A 
(2) Booklet/Leaflet 
(3) Posters in clinic 
(4) Video/DVD/CD 
(5) Group talks 
(6) One on one with doctor/nurse 
(7) Family planning advisor/nurse who came to clinic 
(8) Family planning/Women’s health clinic 














83.  Do you think family planning services can be improved? 
(1) YES 
(2) NO 








 84.  If YES, in what way could services be improved? (List all that 
apply)(SPONTANEOUS INPUT) 
(1) N/A  
(2) Health care practitioners attitudes should change 
(3) Dedicated family planning clinics 
(4) Preconception care clinics 
(5) Family planning advice at your regular cardiac clinic 
(6) Women need contraceptive information/educational material 
(7) Shorter waiting times at  family planning clinics 
(8) Longer or more suitable clinic hours 
(9) Private consultations 
(10)More accessible services 
(11)Specific advice about medical problems 
(12)Other (please specify 
(13) Don’t know 
 




(3) I don’t know 
(4) N/A- already sterilised 
 
       86. Has any healthcare worker ever advised you against pregnancy in the past? 
(1) YES 
(2) NO 
(3) I don’t know 
































REPRODUCTIVE AND CONTRACEPTIVE 
KNOWLEDGE AMONG WOMEN WITH 
HYPERTENSIVE AND CARDIAC DISEASE 







Patient Number:      _____________________ 
Date of Interview:   _____________________ 
Place of Interview:  _____________________ 






30. Date of Birth 
 
 
31. Age (in years and months) 
 
 
32. Population Group  




(12)Foreign African (please specify) 
(13)Foreign Non African (please specify) 
(14)Other (please specify) 
 
 





(10)Other (please specify) 
 
 









(11)Christian Other (please specify) 
(12)Hindu 
(13)Jewish 














RELATIONSHIP STATUS AND SUPPORT 
36. Marital Status 
(8) Single, not in a relationship 
(9) Single in a stable relationship but not cohabiting 











(15)Other Relative/s (please specify) 
(16)Friend/s 
(17)Disability Grant 
(18)Child Support Grant 
(19)No Financial Support 
(20) I don’t know 
 





(14)Other relatives (please specify) 
(15)Friend/s 
(16)Other (please specify) 
(17)No Emotional Support 







39. Highest Level of Education 
(9) No formal schooling                               (9) Grade 8 
(10)Grade 1                                                     (10) Grade 9 
(11)Grade 2                                                     (11) Grade 10 
(12)Grade 3                                                     (12) Grade 11 
(13)Grade 4                                                     (13) Grade 12 
(14)Grade 5                                                     (14) Tertiary (incomplete)                                                
(15)Grade 6                                                     (15) Tertiary (complete) 


















(15)Disability or Other Grant 
(16)Other (please specify) 
 
 
41. What is your job? 
(9) N/A – unemployed 
(10) Housewife 
(11) Domestic Worker 
(12) Factory Worker 
(13) Office Worker 
(14) Professional 




42. Type of Dwelling 
(10)Formal house on separate stand 
(11)Flat 
(12)Semi-detached house 
(13)Separate entrance (room in main dwelling) 
(14)Wendy house (room in backyard) 
(15)Informal Dwelling/Shack 
(16)Room in main dwelling 
(17)Homeless 
(18) Other (please specify) 
 
 
43. Do you own your own home? 
(6) YES 
(7) NO  
(8) N/A 










44. Do you smoke cigarettes? 
(5) YES 
(6) NO, never 
(7) STOPPED less than 6 months ago 
(8) STOPPED more than 6 months ago 
 
45. If YES how many cigarettes a day? 
(7) 0 -10 
(8) 10-20 
(9)  >20 
(10)>30 




46. Do you consume alcohol? 
(6) YES 
(7) NO, never 
(8) STOPPED less than 6 months ago 
(9) STOPPED more than 6months ago 
(10)N/A 
 
47. If YES, how many units/week? 
1 unit of alcohol = 1 glass of wine, a nip or 1 shot of spirit, 1 glass of beer 
(~200mls) 
 <1 = infrequent use 





48. Do you use any recreational drugs? 
(5) YES 
(6) NO, never 
(7) STOPPED less than 6 months ago 
(8) STOPPED more than 6 months ago 
 



















50. Age of first coitus 
 
 
51. Age of first contraception 
 
 
52. Age of menarche 
 
 




If NO, proceed to Question 53(ie. omit questions 25 – 52) 
 
 















Outcome of Each Pregnancy (please enter numbers) 
 















































1.       
2.       
3.       
4.       
5.       




7.       
8.       
9.       






37.  What contraception were you offered after pregnancy? (Must volunteer, 
      mark all that apply) 
(12) Male condoms 
(13) Female condoms 
(14) Combined Oral Contraceptive Pill 
(15) Progesterone Only Pills 
(16) Injectable Contraceptives (progestagens) 
(17) Intrauterine contraceptive Device 
(18) Intrauterine system 
(19) Sterilisation  
(20) Other (please specify) 
(21) N/A (not offered any method) 






38. What was the reason for the TOP? 
(1) Maternal complications due to hypertension 
(2) Maternal complications not related to hypertension 
(3) Fetal complications/abnormality 
(4) Socio-economic reasons 
(5) Unintended pregnancy 

































































1.       
2.       
3.       
4.       
5.       
6.       
7.       
8.       
9.       



































(8) I don’t know 
(9) Already a diagnosed with hypertension before pregnancy 
(10) Diagnosed after pregnancy 
 
 





49.  If yes (in 47), did your blood pressure return to normal after pregnancy? 
(6) Yes, returned to normal after all the pregnancies 
(7) Yes, returned to normal after some but not all the pregnancies 
(8) Never returned to normal 
(9) N/A 
(10) Don’t Know 
 







(6) I can’t remember/I don’t know 
51.  Were you ever using any form of contraception when you conceived? 
(5) YES(Specify which pregnancy)________________________________ 
(6) NO 
(7) I can’t remember/I don’t know 
(8) N/A no previous pregnancies 
(this applies to all pregnancies) 
 
52.  What was the reason if “No” in 51? (Must volunteer) 
(15)Planned Pregnancy 
(16)Did not think I could get pregnant because hypertension made it more 
difficult to conceive 
(17)Previously had not conceived despite not using any contraception 
(18)Previously not conceived despite fertility treatment 
(19)Hoping to fall pregnant although not actively planning it 
(20)I accidentally delayed getting my scheduled contraception 
(21)I stopped contraception because of side effects 
(22)Partner convinced me to stop contraceptive 
(23)Doctors asked me to stop contraception for medical reasons 
(24)Partner said he was sterile 
(25) Contraception difficult to access 
(26) I was sterilised 
(27) N/A I was on contraception 








MEDICAL HISTORY [ALSO FROM NOTES] 
53.   Is there anyone in your family with hypertension? 
(1) Yes 
(2) No 
(3) I don’t know 
 
54.   At what age were you first diagnosed with hypertension? 
 
 




56.  Current Treatment 
 YES NO Don’t Know 
(1)Diuretics- e.g: Lasix    
(2)Beta-blockers-e.g: 
Atenolol 
   
(3)Ace-inhibitors -e.g: 
Enalapril, Angiotensin 
Receptor blockers -e.g: 
Losartan 
   
(4)Calcium channel 
blockers-e.g: Verapamil, 
Amlodipine, Adalat XL 
   
(5)Antiplatelet meds- e.g: 
Aspirin 
   
(6)Anticoagulants- e.g: 
Warfarin 
   
(7)Anticholesterol-e.g: 
Statins 
   
(8)ARV’s    
(9)Other 
(Specify)_____________ 
   
 
 
57.  Do you have any other medical problems? 
(1)Yes 
(2)No 
(3) I don’t know 
 
58.  If yes in 57, what illnesses do you have? 
(1) Cardiac disease 
(2) Diabetes 
(3) Stroke 
(4) Previous thrombo-embolic disease 
(5) Kidney disease 
(6) HIV 
(7) Other (specify) 
(8) I do not know 










59.  Number of scheduled visits to hypertension clinic per year 
(5) 2 or less 
(6) 3 or more 
(7) Referred to Day Hospital or similar 





60.  What complications have you been told can occur as a result of hypertension? 
(must volunteer, tick yes if mentions) 
      YES  NO 
(1) Cardiac disease   
(2) Renal disease   
(3)Stroke   
(4) Retinopathy    
(5)Pregnancy complications   
(6)Malignant hypertension   
(7) None volunteered   




                
                  
 
61.  Do you understand how hypertension can affect a pregnancy? 
(must volunteer, tick yes if mentions) 
 
    YES NO 
(1)growth restriction   
(2)Abruptio placentae   
(3)Pre-eclampsia   
(4)Miscarriage and TOP   
(5)Stillborn   
(6)Preterm birth   


















62.  Do you know how pregnancy affects hypertension in any way? 
(must volunteer, tick yes if mentions)  
 
    YES 
(1)Can worsen hypertension  
(2)Can worsen kidney disease  
(3)Need to change medication  























63.   Have you received any contraception/family planning/pregnancy 






      (1) YES 
             (2) NO 
      (3) Don’t know 
 
 










65.  If NO, why? 
(1)Clinic too busy  
(2)Doctor/Sister too rushed  
(3)Sister/doctor has never initiated topic  
(4)Shy/Uncomfortable to initiate topic with doctor/sister  
(5)Doctor/sister not interested  
(6)Did not think to ask anyone  
(7)Thought this “belonged” elsewhere in the service  
(8)N/A – Received advice/referral  
















66.  Who would you ask for contraceptive advice? 
(1)Parents  
(2)Friends  
(3)Family doctor  
(4)Local Clinic Doctor/Sister  




(9)Family Planning Clinic  
(10)Other Relatives  
(11)Other (please specify)  
(12)Don’t Know  














67.  Would you like your hypertension doctor/sister to start the conversation 
about family planning/contraception? 
(4) YES 
(5) NO 










68.  Do you find it easy to access contraception? 
(4) YES 
(5) NO 
(6) I don’t know(never tried) 
69.  Where do you usually get contraception? 





(15)Other hospital services 
(16)Other (please specify) 
(17)Previous sterilisation 












































70.  Please list all the methods of family planning you KNOW ABOUT? 
[SPONTANEOUS INPUT] 
 
71.  I will then ask you to list all methods you have USED. [SPONTANEOUS INPUT] 
 
 
72.  And which method are you CURRENTLY USING? [SPONTANEOUS INPUT] 
 
 
METHOD 70. KNOW ABOUT 71. USED BEFORE 72. CURRENTLY USING 
a] Pill (COC)    
b] Mini pill (POP)    
c] Injection (Depo)    
d] Loop (IUCD)     
e] IUS (mirena)    
f] Cap/Diaphragm     
g] Male condom    
h] Female Condom    
i] Long term implants    
j] ”Rhythm” method    
k] Withdrawal method    
l] Abstinence    
m] Spermicides    
n] Female sterilisation    
o] Male sterilisation    
p] Morning after pill     
q]Termination/abortion    
r] None of the above    









73.  Have you been given a choice of family planning which was suitable for you? 
(1)YES 
(2)NO 
 (3)I don’t know 
 (4) N/A 
 
 
74.  Do you understand that some contraceptives will not be suitable for you 
because of hypertension? 
(1) Yes 
(2) No  
(3) I don’t know 
 
75.  Do you feel information regarding contraception and hypertension is readily 
available to you? 
(4) YES 
(5) NO 
(6) I don’t know 
 
76.  Do you feel there is enough information regarding pregnancy and 
hypertension available to you? 
(4) YES 
(5) NO 
(6) I don’t know 
 
 
77.  Do you feel that the contraception services available to you are adequate 
and user friendly? 
(5) YES 
(6) NO 
(7) I don’t know 
(8) N/A 
 
78.  Would you value more information regarding contraception, reproductive 
and women’s health specific to hypertension? 
(4) YES 
(5) NO 
(6) I don’t know 
 




(12) Posters in clinic 
(13) Video/DVD/CD 
(14) Group talks 







(16) Family planning advisor/nurse who came to clinic 
(17) Family planning/Women’s health clinic 







80.  Do you think family planning services can be improved? 
(5) YES 
(6) NO 











81.  If YES, in what way could services be improved? (List all that 
apply)(SPONTANEOUS INPUT) 
(14)N/A  
(15)Health care practitioners attitudes should change 
(16)Dedicated family planning clinics 
(17)Preconception care clinics 
(18)Family planning advice at routine hypertension follow up visits 
(19)Women need contraceptive information/educational material 
(20)Shorter waiting times at clinics 
(21)Longer or more suitable clinic hours 
(22)Private consultations 
(23)More accessible services 
(24)Specific advice about medical problems 
(25)Other (please specify) 
(26)Don’t know 
 




(7) I don’t know 
(8) N/A- already sterilised 
       83. Has any healthcare worker ever advised you against pregnancy in the past? 
(4) YES 
(5) NO 
(6) I don’t know 




















































 INFORMATION LEAFLET 
 
REPRODUCTIVE AND CONTRACEPTIVE KNOWLEDGE AMONG WOMEN WITH 
HYPERTENSIVE AND CARDIAC DISEASE                                      REC NO……………..   
     
The Department of Obstetrics and Gynaecology of the University of Cape Town, with support from 
Head of the Department of Medicine, is doing a study at your clinic. It has been approved by the 
Research Ethics Committee at University of Cape Town. We think you are eligible for the study and 
wish to invite you to participate. 
Reason for doing the study 
Every year many women have complications during pregnancy in South Africa, and many of these 
are avoidable. Some women are at higher risk than others, for example women with chronic 
hypertension and cardiac disease. Pregnancies complicated by hypertension and cardiac disease are 
also associated with more complications for the baby, either because of the diagnosis itself or from 
some medication. 
Often women fall pregnant unintentionally, and book late at the antenatal clinic. This is not ideal, 
especially for hypertensive and cardiac women. All this can be avoided or at least reduced by 
planning families, using effective modern contraception, and by ensuring that any medical condition 
is well controlled. It is recommended that cardiac and hypertensive women be counselled by the 
health care workers regularly when they attend their medical clinic, or be referred to family planning 
clinics for the advice and counselling. 
The purpose of the study is to investigate the following: 
1. Knowledge of contraception and pregnancy among hypertensive and cardiac women 
attending a clinic for management of their condition.  
2.  The information about pregnancy and contraception which is given to these women by the 
health care professionals.  
Suitable patients for the study 
1. Women between ages of 18 and 45 
2. Known with chronic hypertension and/or any cardiac disease 
3. Attending a routine medical clinic, and not in need of emergency medical care 
4. Not currently pregnant 
Patients not suitable for the study 
1. Women younger than 18 and older than 45 
2. Pregnant women 
3. Women who do not wish to participate 
The investigators are from the Reproductive Medicine Unit, and are employed by the University of 




interested in participating, the investigators will interview you using a questionnaire. At times they 
may need to review your medical folder to confirm medical information. You will receive your usual 
routine medical care at the clinic, and none of your doctors are involved in the study. The 
questionnaire will take about twenty minutes to complete, and will not delay you at the clinic. 
Risks anticipated 
You will be completing a questionnaire with the help of trained interviewers, and there are no 
specific risks to you. 
Benefits 
The study may not benefit you directly in the short term. If you need immediate assistance about 
contraception, we will refer you to the appropriate department. In the long-term it will assist in 
improving reproductive health services provided to hypertensive and cardiac women. There will be 
no monetary gain for the participants or investigators. 
Confidentiality 
You will be interviewed privately. Your name and contact details will not be available when the data 
are analysed. We do need your name and signature for the consent form, which will not be attached 
to the questionnaire to ensure that there is no link between your answers and your identity. The 
questionnaires will be kept in a secure place, and will be property of the University of Cape Town.  
The research results will be presented by the investigators to the Department of Obstetrics and 
Gynaecology at the University of Cape Town. The study will be submitted to the University of Cape 
Town for completion of a postgraduate degree. 
The health care workers at your clinic will also have eventually access to the results of the study, but 
not your personal contribution, to help improve the services they provide to their patients. 
Contact details 
If you have any further queries regarding this study, please feel free to contact: 
Dr Nwabisa Giyose: Principal investigator.  Department of Obstetrics and Gynaecology, University of 
Cape Town.  
 Telephone: 0736466152 
 Email: drgiyose@yahoo.co.uk  
Professor Van Der Spuy,  Supervisor, Department of Obstetrics and Gynaecology, University of Cape 
Town. Telephone: 021-404 4484 
If you wish to discuss this research with someone who is not involved in the study, you may contact:  
Dr M Patel, sub-specialist in Reproductive Medicine.  Telephone: 021- 404 6026 
Prof Marc Blockman,  Chairman of Research Ethics Committee, Faculty of Health Sciences: 





























REPRODUCTIVE AND CONTRACEPTIVE KNOWLEDGE AMONG WOMEN WITH 
HYPERTENSIVE AND CARDIAC DISEASE  
STUDY NUMBER: ……………………………………….. 
(REC NO………………….) 
I agree to participate in the study that is being conducted by researchers from Department 
of Obstetrics and Gynaecology. It has been approved by the Research Ethics Committee of 
the Faculty of Health Sciences. 
The study has been fully explained to me in a language of my choice by a member of 
Reproductive Medicine Unit. I understand the purpose of the study is to investigate 
reproductive knowledge and practices of women with hypertension and cardiac disease, 
with the aim to improve reproductive health services for these women. 
The results of the study will be submitted as part of a postgraduate degree to the University 
of Cape Town. 
I understand I may withdraw from the study without compromising my medical care. There 
will be no payment made to me for participating 
I will be interviewed in private, and my identity will be kept anonymous. I will complete a 
questionnaire with assistance from a member of the Reproductive Medicine Unit. 
Name of participant                                                Signature of participant 
…………………………….                                               …………………………………. 
Name of the researcher                                 Signature of researcher 
……………………………                                        …………………………………. 
Name of witness                                          Signature of a witness 
…………………………….                                ………………………………… 
Date…………………… 
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